The Burden of Short-Acting Β2-Agonists Use in Asthma: Is There an Italian Case? An Update From SABINA Program

Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

Verfasser: Adis journals on behalf of (9646730)
Fabiano Di Marco (10730845)
Mariella D’Amato (8920135)
Francesco P. Lombardo (10730846)
Claudio Micheletto (3827746)
Franca Heiman (10730848)
Valeria Pegoraro (9142956)
Silvia Boarino (10730853)
Giandomenico Manna (10730858)
Francesca Mastromauro (10730860)
Simona Spennato (10730861)
Alberto Papi (347149)
Dokumenttyp: Dataset
Erscheinungsdatum: 2021
Schlagwörter: Medicine / Respiratory Diseases / asthma / SABA consumption / guidelines recommendations / exacerbations / primary care / real world evidence
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-27649024
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.6084/m9.figshare.14519592.v1